These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27167507)

  • 21. West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV-Platelets system.
    Gravemann U; Boelke M; Könenkamp L; Söder L; Maurer M; Ziegler U; Schulze TJ; Seltsam A; Becker SC; Steffen I
    Vox Sang; 2024 Aug; 119(8):827-833. PubMed ID: 38699884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation.
    Johnson L; Hyland R; Tan S; Tolksdorf F; Sumian C; Seltsam A; Marks D
    Transfus Med Hemother; 2016 May; 43(3):190-7. PubMed ID: 27403091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance of platelet concentrates treated with UVC-light only for pathogen reduction--a phase I clinical trial.
    Thiele T; Pohler P; Kohlmann T; Sümnig A; Aurich K; Selleng K; Westphal A; Bakchoul T; Petersmann A; Müller TH; Greinacher A; Seltsam A
    Vox Sang; 2015 Jul; 109(1):44-51. PubMed ID: 25754418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model.
    Pohler P; Lehmann J; Veneruso V; Tomm J; von Bergen M; Lambrecht B; Kohn B; Weingart C; Müller TH; Seltsam A
    Transfusion; 2012 Nov; 52(11):2414-26. PubMed ID: 22404822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function.
    Knutson F; Alfonso R; Dupuis K; Mayaudon V; Lin L; Corash L; Högman CF
    Vox Sang; 2000; 78(4):209-16. PubMed ID: 10895093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.
    Hechler B; Ohlmann P; Chafey P; Ravanat C; Eckly A; Maurer E; Mangin P; Isola H; Cazenave JP; Gachet C
    Transfusion; 2013 Jun; 53(6):1187-200. PubMed ID: 23067365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
    Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
    Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.
    Mohr H; Gravemann U; Bayer A; Müller TH
    Transfusion; 2009 Sep; 49(9):1956-63. PubMed ID: 19497057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital droplet polymerase chain reaction to monitor ultraviolet C treatment of single-donor and buffy coat platelet units.
    Voglau U; Müller TH; Seltsam A; Gravemann U; Handke W; Doescher A
    Transfusion; 2020 Aug; 60(8):1821-1827. PubMed ID: 32537745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of platelet concentrates with ultraviolet C light for pathogen reduction increases cytokine accumulation.
    Sandgren P; Berlin G; Tynngård N
    Transfusion; 2016 Jun; 56(6):1377-83. PubMed ID: 27080102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality control of riboflavin-treated platelet concentrates using Mirasol® PRT system: Polish experience.
    Lachert E; Kubis J; Antoniewicz-Papis J; Rosiek A; Woźniak J; Piotrowski D; Przybylska Z; Mikołowska A; Marschner S; Łętowska M
    Adv Clin Exp Med; 2018 Jun; 27(6):765-772. PubMed ID: 29877637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.
    Sandgren P; Diedrich B
    Vox Sang; 2015 May; 108(4):340-9. PubMed ID: 25557354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
    Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
    Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro thrombus formation and in vivo hemostasis mediated by platelets irradiated with bactericidal ultraviolet C from xenon flash under flow conditions.
    Abe H; Endo K; Nogawa M; Shiba M; Miyata S; Satake M
    Transfusion; 2021 Jan; 61(1):191-201. PubMed ID: 33107611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
    Kaiser-Guignard J; Canellini G; Lion N; Abonnenc M; Osselaer JC; Tissot JD
    Blood Rev; 2014 Nov; 28(6):235-41. PubMed ID: 25192602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.